Trial evaluated number of supplemental injections needed for the treatment of DME for patients on ILUVIEN versus the ...

Treatments for uveitic macular edema, including systemic and local options, were among the topics debated at the Congress on Controversies in Ophthalmology.

SNS Insider Reveals Sharp Growth in U.S. Retinal Biologics Market, Valued at USD 9.70 Billion in 2023 Capturing Over 43% Global Share Amid FDA Approvals, VEGF-A Dominance, and Accelerating R&D in ...

In a statement, the Army said, "Army hospital R& R successfully performed Auditory brainstem implant - a rare, life-changing procedure in a 1.8-year-old d/o of a serving soldier, a case of Michel ...

Let’s get to know Dr. Brittany Setzer of the Missouri Eye Institute. Missouri Eye Institute’s conveniently located offices in ...

The results showed that the median time to first diabetic macular oedema resolution in the DEX group was 9.0 months [95% CI: 8.5–9.3]. The hazard ratio for DME resolution comparing DEX to sham was ...

BVI is a winner in the Research and Development, Investments, and Product Launches categories in the 2025 Medical Device Network Excellence Awards.

Boehringer Ingelheim has raised hopes of a more patient-friendly option with the start of phase 2 testing of BI 1815368, ...

In recent years, the issue of correcting higher-order aberrations has become increasingly relevant, particularly in patients ...

Remedy Medical Properties acquired the Dupont Office Center in Bloomington for $10.9M, marking its second Twin Cities medical real estate deal in weeks.